rs885813

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000478.6(ALPL):​c.-104-3397C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 151,810 control chromosomes in the GnomAD database, including 11,067 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 11067 hom., cov: 31)

Consequence

ALPL
NM_000478.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.993

Publications

8 publications found
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
  • adult hypophosphatasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • childhood hypophosphatasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
  • hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
  • infantile hypophosphatasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • odontohypophosphatasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • perinatal lethal hypophosphatasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.434 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.-104-3397C>T intron_variant Intron 1 of 11 ENST00000374840.8 NP_000469.3 P05186-1A0A024RAB4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.-104-3397C>T intron_variant Intron 1 of 11 1 NM_000478.6 ENSP00000363973.3 P05186-1
ENSG00000289715ENST00000696766.1 linkc.119+3059C>T intron_variant Intron 1 of 1 ENSP00000512858.1 A0A8Q3SIZ7

Frequencies

GnomAD3 genomes
AF:
0.372
AC:
56487
AN:
151692
Hom.:
11058
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.466
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.500
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.266
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.438
Gnomad OTH
AF:
0.390
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.372
AC:
56518
AN:
151810
Hom.:
11067
Cov.:
31
AF XY:
0.366
AC XY:
27158
AN XY:
74154
show subpopulations
African (AFR)
AF:
0.299
AC:
12370
AN:
41334
American (AMR)
AF:
0.343
AC:
5231
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1734
AN:
3470
East Asian (EAS)
AF:
0.167
AC:
863
AN:
5166
South Asian (SAS)
AF:
0.266
AC:
1277
AN:
4802
European-Finnish (FIN)
AF:
0.368
AC:
3885
AN:
10548
Middle Eastern (MID)
AF:
0.476
AC:
139
AN:
292
European-Non Finnish (NFE)
AF:
0.438
AC:
29774
AN:
67922
Other (OTH)
AF:
0.390
AC:
822
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1769
3537
5306
7074
8843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.422
Hom.:
58835
Bravo
AF:
0.369
Asia WGS
AF:
0.240
AC:
835
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.4
DANN
Benign
0.40
PhyloP100
-0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs885813; hg19: chr1-21877074; API